Evidence map›Paper›PMID 24525598›Full record

Trial reportPeritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.

Oscar Orihuela, María de Jesús Ventura, Marcela Ávila-Díaz, Alejandra Cisneros, Marlén Vicenté-Martínez, María-del-Carmen Furlong, Zuzel García-González, Diana Villanueva, Guadalupe Alcántara, Bengt Lindholm and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Biocompatible dialysis fluids for peritoneal dialysis.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Oscar OrihuelaUnidad de Investigación Médica en Enfermedades Nefrológicas,1 Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), México City;
María de Jesús Ventura
Marcela Ávila-Díaz
Alejandra Cisneros
Marlén Vicenté-Martínez
María-del-Carmen Furlong
Zuzel García-González
Diana Villanueva
Guadalupe Alcántara
Bengt Lindholm
Elvia García-López
Cleva Villanueva
Ramón Paniagua
Hospital General De Zona · MXCentro Medico Nacional Siglo XXI · MXHospital de Especialidades · MXKarolinska Institutet · SEInstituto Politécnico Nacional · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelled

introductionSpectral analysis of heart rate variability is a noninvasive method for evaluating autonomic cardiovascular dysfunction under various clinical conditions, such as in dialysis patients, in whom an imbalance between the sympathetic and parasympathetic nervous system appears to be an important risk factor for sudden cardiovascular death and arrhythmia. ♢

objectiveWe compared the effect of icodextrin-based dialysis solution, an option that allows for better metabolic and fluid overload control, with that of glucose-based dialysis fluid on sympathetic and parasympathetic activity in the heart, as assessed by heart rate variability, in diabetic patients on peritoneal dialysis (PD). ♢

methodsThis secondary analysis uses data from a randomized controlled trial in diabetic PD patients with high or high-average peritoneal transport using icodextrin-based (ICO group, n = 30) or glucose-based (GLU group, n = 29) solutions for the long dwell. All patients underwent 24-hour electrocardiographic Holter monitoring at baseline, and at 6 and 12 months of follow-up. ♢

resultsWe observed no significant differences between the groups in most of the variables analyzed, although values were, in general, below reference values. In the ICO group, total power and both low- and high-frequency power in normalized units increased, but the percentage of RR intervals with variation of more than 50 ms declined over time; in the GLU group, all those values declined. Plasma catecholamine levels were higher at baseline and declined over time. ♢

conclusionsThese results indicate a partial recovery of sympathetic activity in the ICO group, probably because of better extracellular fluid control and lower exposure to glucose with the use of icodextrin-based dialysis solutions.

Indexed as

Peritoneal DialysisDeath, Sudden, CardiacDiabetes Mellitus, Type 2Dialysis SolutionsFemaleGlucansGlucoseHeart RateHumansIcodextrinMaleMiddle AgedDialysis SolutionsGlucansGlucoseIcodextrindiabetesEnd-stage renal diseaseheart rate variabilityhigh peritoneal transport typeicodextrin

Identifiers

PMID24525598
PMCPMC3923693
OpenAlexW2325931252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.